Clinical Trial Update: Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of Travoprost 0.004% on retinal oximetry in primary open-angle glaucoma, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Travoprost 0.004% (travoprost)

Snippet

Sponsor: Université de Montréal | Conditions: Primary Open Angle Glaucoma | NA | Status: COMPLETED | Results posted: 2016-07-28